Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-29

Clinical Trial Update: A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the OMNI Surgical System to standard medical therapy for primary open-angle glaucoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OMNI Surgical System

Snippet

Sponsor: Sight Sciences, Inc. | Conditions: Primary Open Angle Glaucoma | Phase 4 | Status: TERMINATED